SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.35%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$396M
AUM Growth
+$396M
(+11%)
Cap. Flow
-$33.8M
Cap. Flow
% of AUM
-8.54%
Top 10 Holdings %
Top 10 Hldgs %
35.42%
Holding
254
New
59
Increased
32
Reduced
45
Closed
40
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$22.4M |
| 2 |
Exxon Mobil
XOM
|
$14.8M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
$10.6M |
| 4 |
Merck
MRK
|
$8.74M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$8M |
Top Sells
| 1 |
Tempest Therapeutics
TPST
|
$49.8M |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
$40.7M |
| 3 |
AGN
Allergan plc
AGN
|
$33.8M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$24.7M |
| 5 |
MBLY
Mobileye N.V.
MBLY
|
$8.1M |
Sector Composition
| 1 | Healthcare | 57.32% |
| 2 | Energy | 8.8% |
| 3 | Technology | 1.44% |
| 4 | Communication Services | 1.02% |
| 5 | Industrials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $28.9M | 1.05% | 246,000 +190,680 | +345% | +$22.4M |
|
|
2
Merck
MRK
$210B
| $17.9M | 0.65% | 314,285 +153,581 | +96% | +$8.74M |
|
|
3
Exxon Mobil
XOM
$487B
| $14.8M | 0.54% | +178,310 | New | +$14.8M |
|
|
PXD
4
DELISTED
Pioneer Natural Resource Co.
PXD
| $10.6M | 0.39% | +76,273 | New | +$10.6M |
|
|
5
Tempest Therapeutics
TPST
$44M
| $10.3M | 0.37% | 355,000 -1,719,736 | -83% | -$49.8M |
|
|
ZGNX
6
DELISTED
Zogenix, Inc.
ZGNX
| $10M | 0.37% | 5,963,095 -2,455,716 | -29% | -$4.13M |
|
7
Tenax Therapeutics
TENX
$27.3M
| $9.91M | 0.36% | 2,686,247 -130,374 | -5% | -$481K |
|
|
IOC
8
DELISTED
Interoil Corporation
IOC
| $9.22M | 0.34% | 153,144 -49,788 | -25% | -$3M |
|
9
Pluri
PLUR
$41.5M
| $8.22M | 0.3% | 3,261,642 +3,086,642 | +1,764% | +$7.78M |
|
|
BPMC
10
DELISTED
Blueprint Medicines
BPMC
| $8M | 0.29% | +301,804 | New | +$8M |
|
11
Inovio Pharmaceuticals
INO
$126M
| $7.39M | 0.27% | +906,000 | New | +$7.39M |
|
|
APC
12
DELISTED
Anadarko Petroleum
APC
| $7.1M | 0.26% | +90,971 | New | +$7.1M |
|
|
ALPN
13
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $6.52M | 0.24% | +430,041 | New | +$6.52M |
|
14
Lipocine
LPCN
$15.8M
| $6.22M | 0.23% | +725,000 | New | +$6.22M |
|
|
BLCM
15
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $5.13M | 0.19% | 241,039 +9,524 | +4% | +$203K |
|
|
ASXC
16
DELISTED
Asensus Surgical, Inc.
ASXC
| $5.06M | 0.18% | +1,685,800 | New | +$5.06M |
|
|
VXZ
17
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
| $5.03M | 0.18% | +450,000 | New | +$5.03M |
|
|
DERM
18
DELISTED
Dermira, Inc.
DERM
| $4.86M | 0.18% | 276,994 -108,191 | -28% | -$1.9M |
|
|
ONCS
19
DELISTED
OncoSec Medical Incorporated
ONCS
| $4.86M | 0.18% | +767,733 | New | +$4.86M |
|
|
MNK
20
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $4.77M | 0.17% | 40,539 +33,259 | +457% | +$3.92M |
|
21
Cidara Therapeutics
CDTX
$1.66B
| $4.14M | 0.15% | +294,982 | New | +$4.14M |
|
|
FNCX
22
DELISTED
Function(x) Inc.
FNCX
| $4.05M | 0.15% | +1,976,911 | New | +$4.05M |
|
23
Standard BioTools
LAB
$481M
| $4M | 0.15% | +165,385 | New | +$4M |
|
|
MBLY
24
DELISTED
Mobileye N.V.
MBLY
| $3.93M | 0.14% | 73,832 -152,248 | -67% | -$8.1M |
|
25
Iovance Biotherapeutics
IOVA
$807M
| $3.92M | 0.14% | 427,244 +52,010 | +14% | +$477K |
|